Is axillary reverse mapping feasible in breast cancer patients?
Identifieur interne : 000E49 ( PubMed/Checkpoint ); précédent : 000E48; suivant : 000E50Is axillary reverse mapping feasible in breast cancer patients?
Auteurs : M. Noguchi [Japon] ; S. Miura [Japon] ; E. Morioka [Japon] ; Y. Ohno [Japon] ; M. Yokoi-Noguchi [Japon] ; Y. Nakano [Japon] ; T. Kosaka [Japon]Source :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 1532-2157 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Noeuds lymphatiques, Tumeurs du sein.
- effets indésirables : Lymphadénectomie.
- Aisselle, Biopsie de noeud lymphatique sentinelle, Colorants fluorescents, Humains, Lymphadénectomie, Lymphoedème, Métastase lymphatique, Radio-isotopes.
English descriptors
- KwdEn :
- MESH :
- chemical : Fluorescent Dyes, Radioisotopes.
- adverse effects : Lymph Node Excision.
- methods : Lymph Node Excision.
- pathology : Breast Neoplasms, Lymph Nodes.
- prevention & control : Lymphedema.
- Axilla, Humans, Lymphatic Metastasis, Sentinel Lymph Node Biopsy.
Abstract
In the surgical treatment of breast cancer, axillary lymph node dissection (ALND) can be avoided not only in sentinel lymph node (SLN)-negative patients but also in SLN-positive patients who undergo breast-conserving surgery with whole-breast irradiation and systemic therapy. However, it should be performed not only in clinically node-positive patients but also in other SLN-positive patients who do not meet the Z-0011 criteria. The axillary reverse mapping (ARM) technique has been developing for identifying and preserving lymphatic drainage from the arm during ALND, thereby expected to minimize arm lymphedema. Nevertheless, ARM nodes could be involved not only in clinically node-positive patients but also in clinically node-negative patients. Previously, it was considered that preservation of the ARM lymphatics or lymph nodes is not oncologically safe in patients with axillary lymph node metastases. However, recent studies have demonstrated that the ARM procedure is oncologically feasible in clinically node-negative, SLN-positive patients when ARM nodes do not coincide with SLNs. When ARM nodes do not coincide with SLNs, they are not involved even in SLN-positive patients. On the other hand, ARM lymphatics/nodes within the boundaries of a standard ALND should be resected in SLN-positive patients, when ARM nodes are SLN-ARM nodes. Therefore, surgical treatment of the axilla can be individualized on the basis of the axillary nodal status.
DOI: 10.1016/j.ejso.2015.01.029
PubMed: 25704555
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25704555Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is axillary reverse mapping feasible in breast cancer patients?</title><author><name sortKey="Noguchi, M" sort="Noguchi, M" uniqKey="Noguchi M" first="M" last="Noguchi">M. Noguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan. Electronic address: nogumasa@kanazawa-med.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Miura, S" sort="Miura, S" uniqKey="Miura S" first="S" last="Miura">S. Miura</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Morioka, E" sort="Morioka, E" uniqKey="Morioka E" first="E" last="Morioka">E. Morioka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Ohno, Y" sort="Ohno, Y" uniqKey="Ohno Y" first="Y" last="Ohno">Y. Ohno</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Yokoi Noguchi, M" sort="Yokoi Noguchi, M" uniqKey="Yokoi Noguchi M" first="M" last="Yokoi-Noguchi">M. Yokoi-Noguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Nakano, Y" sort="Nakano, Y" uniqKey="Nakano Y" first="Y" last="Nakano">Y. Nakano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Kosaka, T" sort="Kosaka, T" uniqKey="Kosaka T" first="T" last="Kosaka">T. Kosaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Oncology, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Surgical Oncology, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25704555</idno><idno type="pmid">25704555</idno><idno type="doi">10.1016/j.ejso.2015.01.029</idno><idno type="wicri:Area/PubMed/Corpus">001031</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001031</idno><idno type="wicri:Area/PubMed/Curation">001031</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001031</idno><idno type="wicri:Area/PubMed/Checkpoint">001031</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001031</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Is axillary reverse mapping feasible in breast cancer patients?</title><author><name sortKey="Noguchi, M" sort="Noguchi, M" uniqKey="Noguchi M" first="M" last="Noguchi">M. Noguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan. Electronic address: nogumasa@kanazawa-med.ac.jp.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Miura, S" sort="Miura, S" uniqKey="Miura S" first="S" last="Miura">S. Miura</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Morioka, E" sort="Morioka, E" uniqKey="Morioka E" first="E" last="Morioka">E. Morioka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Ohno, Y" sort="Ohno, Y" uniqKey="Ohno Y" first="Y" last="Ohno">Y. Ohno</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Yokoi Noguchi, M" sort="Yokoi Noguchi, M" uniqKey="Yokoi Noguchi M" first="M" last="Yokoi-Noguchi">M. Yokoi-Noguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Nakano, Y" sort="Nakano, Y" uniqKey="Nakano Y" first="Y" last="Nakano">Y. Nakano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author><author><name sortKey="Kosaka, T" sort="Kosaka, T" uniqKey="Kosaka T" first="T" last="Kosaka">T. Kosaka</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgical Oncology, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Surgical Oncology, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa</wicri:regionArea><wicri:noRegion>Ishikawa</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="eISSN">1532-2157</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Fluorescent Dyes</term><term>Humans</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (methods)</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis</term><term>Lymphedema (prevention & control)</term><term>Radioisotopes</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Aisselle</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Colorants fluorescents</term><term>Humains</term><term>Lymphadénectomie ()</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème ()</term><term>Métastase lymphatique</term><term>Noeuds lymphatiques (anatomopathologie)</term><term>Radio-isotopes</term><term>Tumeurs du sein (anatomopathologie)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Fluorescent Dyes</term><term>Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Noeuds lymphatiques</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term><term>Lymph Nodes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Axilla</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Sentinel Lymph Node Biopsy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Aisselle</term><term>Biopsie de noeud lymphatique sentinelle</term><term>Colorants fluorescents</term><term>Humains</term><term>Lymphadénectomie</term><term>Lymphoedème</term><term>Métastase lymphatique</term><term>Radio-isotopes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the surgical treatment of breast cancer, axillary lymph node dissection (ALND) can be avoided not only in sentinel lymph node (SLN)-negative patients but also in SLN-positive patients who undergo breast-conserving surgery with whole-breast irradiation and systemic therapy. However, it should be performed not only in clinically node-positive patients but also in other SLN-positive patients who do not meet the Z-0011 criteria. The axillary reverse mapping (ARM) technique has been developing for identifying and preserving lymphatic drainage from the arm during ALND, thereby expected to minimize arm lymphedema. Nevertheless, ARM nodes could be involved not only in clinically node-positive patients but also in clinically node-negative patients. Previously, it was considered that preservation of the ARM lymphatics or lymph nodes is not oncologically safe in patients with axillary lymph node metastases. However, recent studies have demonstrated that the ARM procedure is oncologically feasible in clinically node-negative, SLN-positive patients when ARM nodes do not coincide with SLNs. When ARM nodes do not coincide with SLNs, they are not involved even in SLN-positive patients. On the other hand, ARM lymphatics/nodes within the boundaries of a standard ALND should be resected in SLN-positive patients, when ARM nodes are SLN-ARM nodes. Therefore, surgical treatment of the axilla can be individualized on the basis of the axillary nodal status.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25704555</PMID><DateCreated><Year>2015</Year><Month>03</Month><Day>30</Day></DateCreated><DateCompleted><Year>2015</Year><Month>05</Month><Day>26</Day></DateCompleted><DateRevised><Year>2016</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>4</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Is axillary reverse mapping feasible in breast cancer patients?</ArticleTitle><Pagination><MedlinePgn>442-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2015.01.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(15)00066-9</ELocationID><Abstract><AbstractText>In the surgical treatment of breast cancer, axillary lymph node dissection (ALND) can be avoided not only in sentinel lymph node (SLN)-negative patients but also in SLN-positive patients who undergo breast-conserving surgery with whole-breast irradiation and systemic therapy. However, it should be performed not only in clinically node-positive patients but also in other SLN-positive patients who do not meet the Z-0011 criteria. The axillary reverse mapping (ARM) technique has been developing for identifying and preserving lymphatic drainage from the arm during ALND, thereby expected to minimize arm lymphedema. Nevertheless, ARM nodes could be involved not only in clinically node-positive patients but also in clinically node-negative patients. Previously, it was considered that preservation of the ARM lymphatics or lymph nodes is not oncologically safe in patients with axillary lymph node metastases. However, recent studies have demonstrated that the ARM procedure is oncologically feasible in clinically node-negative, SLN-positive patients when ARM nodes do not coincide with SLNs. When ARM nodes do not coincide with SLNs, they are not involved even in SLN-positive patients. On the other hand, ARM lymphatics/nodes within the boundaries of a standard ALND should be resected in SLN-positive patients, when ARM nodes are SLN-ARM nodes. Therefore, surgical treatment of the axilla can be individualized on the basis of the axillary nodal status.</AbstractText><CopyrightInformation>Copyright © 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noguchi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan. Electronic address: nogumasa@kanazawa-med.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miura</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morioka</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohno</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokoi-Noguchi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Breast and Endocrine Surgery, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosaka</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgical Oncology, Kanazawa Medical University Hospital, Uchinada-daigaku, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005456">Fluorescent Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011868">Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Surg Oncol. 2016 Jan;42(1):78</RefSource><PMID Version="1">26256851</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Surg Oncol. 2016 Jan;42(1):153-4</RefSource><PMID Version="1">26437854</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005456" MajorTopicYN="N">Fluorescent Dyes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011868" MajorTopicYN="N">Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axillary reverse mapping</Keyword><Keyword MajorTopicYN="N">Breast carcinoma</Keyword><Keyword MajorTopicYN="N">Fluorescence imaging system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>01</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25704555</ArticleId><ArticleId IdType="pii">S0748-7983(15)00066-9</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2015.01.029</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Noguchi, M" sort="Noguchi, M" uniqKey="Noguchi M" first="M" last="Noguchi">M. Noguchi</name></noRegion><name sortKey="Kosaka, T" sort="Kosaka, T" uniqKey="Kosaka T" first="T" last="Kosaka">T. Kosaka</name><name sortKey="Miura, S" sort="Miura, S" uniqKey="Miura S" first="S" last="Miura">S. Miura</name><name sortKey="Morioka, E" sort="Morioka, E" uniqKey="Morioka E" first="E" last="Morioka">E. Morioka</name><name sortKey="Nakano, Y" sort="Nakano, Y" uniqKey="Nakano Y" first="Y" last="Nakano">Y. Nakano</name><name sortKey="Ohno, Y" sort="Ohno, Y" uniqKey="Ohno Y" first="Y" last="Ohno">Y. Ohno</name><name sortKey="Yokoi Noguchi, M" sort="Yokoi Noguchi, M" uniqKey="Yokoi Noguchi M" first="M" last="Yokoi-Noguchi">M. Yokoi-Noguchi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000E49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25704555
|texte= Is axillary reverse mapping feasible in breast cancer patients?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25704555" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |